
What We Can't Reveal We Can't Heal
Given recent events around George Floyd and far beyond, this special episode of the a16z Podcast features Shaka Senghor, a leading advocate for criminal justice reform (and bestselling author), and Te...
4 Kesä 20201h 1min

SaaS Go-to-Upmarket
For a SaaS company, it's easier to move upmarket than down, and this gives SaaS startups the advantage against incumbents. In this episode, David Ulevitch and our newest enterprise general partner Kr...
29 Touko 202021min

New Fan Engagement Models for Athletes and Influencers
Today’s episode is about a practical application of crypto — namely, the way it can “tokenize” fandom. More broadly, it’s about fan engagement, and the increasingly blurred lines between sports, cultu...
26 Touko 202019min

Don't Call it a Brain in a Dish!
Our understanding of the human brain and its disorders has always been limited by our lack of access to living, human, developing brain tissue. For the first time, that's changing. In this episode, Se...
24 Touko 202043min

Pandemics: Early Detection, Networks, Spreaders
Pandemics are predictable; what's not predictable is the intensity, or the precise timing of arrival. That's where early detection -- not just rapid warning (as with something like Google Flu Trends b...
23 Touko 202034min

Podcasting and the Future of Audio
This podcast (first recorded in 2019, now being rerun) -- is a podcast about podcasting: But it's really all about audio. A lot's changed... and a lot hasn't. How do we define "podcasts"; how does the...
20 Touko 20201h 6min

Growth in Turbulent Times
In normal times, every company operates against some hypothetical growth model—a data-driven framework that describes how your product grows and how you acquire new users. These, of course, are not no...
15 Touko 202036min

Journal Club: Using CRISPR to Prevent Coronavirus and Influenza Infection
In this episode of a16z bio Journal Club, general partner Vijay Pande, bio deal team partner Andy Tran, and bio editor Lauren Richardson discuss a novel CRISPR-Cas-based anti-viral strategy.The discus...
15 Touko 202017min





















